EGFR and non-small cell lung carcinoma: This study provided a good reference for the timing of TKI combined with radiotherapy in patients with brain metastases of EGFR-mutated NSCLC, clinical data for the development of treatment mode in such patients, and a useful exploration for improving the quality of life of the patients.